FDA Logo links to FDA home pageSkip Navigation
U.S. Food and Drug Administration
 HHS Logo links to Department of Health and Human Services website
Skip navigationFDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status | Federal Register
horizonal rule

 

Antiviral Drugs Advisory Committee

May 19, 2005

Briefing Information

NDA 021-814 APTIVUS (Tipranavir) 250 mg Capsules

Food and Drug Administration Briefing Information htm Word pdf

Disclaimer

The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Boehringer Ingelheim Briefing Information htm Word pdf

Page updated: May 19, 2005

horizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Federal Registers
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management
[Skip Navigation] link to FDA home page link to U.S. Department of Health and Human Services FDA logo--link to FDA home page